CLINICAL_TRIALS
trial_result
· 2022-03-02
Clinical Trial Update: Fruquintinib in the Treatment of Soft Tissue Sarcoma [Phase 2]
Summary
Phase 2 clinical trial update for Fruquintinib in soft tissue sarcoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Fudan University | Conditions: Soft Tissue Sarcoma | Phase 2 | Status: UNKNOWN